| Literature DB >> 30463913 |
Xiaoxia Zhong1, Andreas Prinz1, Julia Steger1, Maria-Paz Garcia-Cuellar1, Markus Radsak2, Abderrazzak Bentaher3, Robert K Slany1.
Abstract
Ectopic expression of the oncogenic transcription factor HoxA9 is a major cause of acute myeloid leukemia (AML). Here, we demonstrate that HoxA9 is a specific substrate of granule proteases. Protease knockout allowed the comprehensive determination of genome-wide HoxA9 binding sites by chromatin immunoprecipitation sequencing in primary murine cells and a human AML cell line. The kinetics of enhancer activity and transcription rates in response to alterations of an inducible HoxA9 were determined. This permitted identification of HoxA9-controlled enhancers and promoters, allocation to their respective transcription units, and discrimination against HoxA9-bound, but unresponsive, elements. HoxA9 triggered an elaborate positive-feedback loop that drove expression of the complete Hox-A locus. In addition, it controlled key oncogenic transcription factors Myc and Myb and directly induced the cell cycle regulators Cdk6 and CyclinD1, as well as telomerase, drawing the essential blueprint for perturbation of proliferation by leukemogenic HoxA9 expression.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30463913 PMCID: PMC6258913 DOI: 10.1182/bloodadvances.2018025866
Source DB: PubMed Journal: Blood Adv ISSN: 2473-9529